Nakamura Y - Search Results

1

A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer.

Kato Y, Zembutsu H, Takata R, Matsuura T, Kato R, Kanehira M, Iwasaki K, Yamada N, Katagiri T, Sugai T, Fujioka T, Nakamura Y, Obara W. Kato Y, et al. Among authors: nakamura y. Oncol Lett. 2018 Nov;16(5):5775-5784. doi: 10.3892/ol.2018.9330. Epub 2018 Aug 20. Oncol Lett. 2018. PMID: 30333861 Free PMC article.

2

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.

Takata R, Katagiri T, Kanehira M, Tsunoda T, Shuin T, Miki T, Namiki M, Kohri K, Matsushita Y, Fujioka T, Nakamura Y. Takata R, et al. Among authors: nakamura y. Clin Cancer Res. 2005 Apr 1;11(7):2625-36. doi: 10.1158/1078-0432.CCR-04-1988. Clin Cancer Res. 2005. PMID: 15814643 Clinical Trial.

3

Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.

Takata R, Katagiri T, Kanehira M, Shuin T, Miki T, Namiki M, Kohri K, Tsunoda T, Fujioka T, Nakamura Y. Takata R, et al. Among authors: nakamura y. Cancer Sci. 2007 Jan;98(1):113-7. doi: 10.1111/j.1349-7006.2006.00366.x. Cancer Sci. 2007. PMID: 17116130 Free PMC article.

4

Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.

Zembutsu H, Yanada M, Hishida A, Katagiri T, Tsuruo T, Sugiura I, Takeuchi J, Usui N, Naoe T, Nakamura Y, Ohno R. Zembutsu H, et al. Among authors: nakamura y. Int J Oncol. 2007 Aug;31(2):313-22. Int J Oncol. 2007. PMID: 17611687

5

Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.

Zembutsu H, Suzuki Y, Sasaki A, Tsunoda T, Okazaki M, Yoshimoto M, Hasegawa T, Hirata K, Nakamura Y. Zembutsu H, et al. Among authors: nakamura y. Int J Oncol. 2009 Feb;34(2):361-70. Int J Oncol. 2009. PMID: 19148470

6

Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.

Obara W, Ohsawa R, Kanehira M, Takata R, Tsunoda T, Yoshida K, Takeda K, Katagiri T, Nakamura Y, Fujioka T. Obara W, et al. Among authors: nakamura y. Jpn J Clin Oncol. 2012 Jul;42(7):591-600. doi: 10.1093/jjco/hys069. Epub 2012 May 25. Jpn J Clin Oncol. 2012. PMID: 22636067 Clinical Trial.

7

Expression of hypoxia-inducible protein 2 in renal cell carcinoma: A promising candidate for molecular targeting therapy.

Seo T, Konda R, Sugimura J, Iwasaki K, Nakamura Y, Fujioka T. Seo T, et al. Among authors: nakamura y. Oncol Lett. 2010 Jul;1(4):697-701. doi: 10.3892/ol_00000122. Epub 2010 Jul 1. Oncol Lett. 2010. PMID: 22966366 Free PMC article.

8

Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling.

Kato Y, Zembutsu H, Takata R, Miya F, Tsunoda T, Obara W, Fujioka T, Nakamura Y. Kato Y, et al. Among authors: nakamura y. Exp Ther Med. 2011 Jan;2(1):47-56. doi: 10.3892/etm.2010.166. Epub 2010 Nov 30. Exp Ther Med. 2011. PMID: 22977468 Free PMC article.

9

Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.

Obara W, Sato F, Takeda K, Kato R, Kato Y, Kanehira M, Takata R, Mimata H, Sugai T, Nakamura Y, Fujioka T. Obara W, et al. Among authors: nakamura y. Cancer Sci. 2017 Jul;108(7):1452-1457. doi: 10.1111/cas.13278. Epub 2017 Jun 23. Cancer Sci. 2017. PMID: 28498618 Free PMC article. Clinical Trial.

10

Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.

Obara W, Hara I, Kato Y, Kato R, Inoue K, Sato F, Mimata H, Nakamura Y, Fujioka T. Obara W, et al. Among authors: nakamura y. Cancer Immunol Immunother. 2018 Sep;67(9):1371-1380. doi: 10.1007/s00262-018-2197-x. Epub 2018 Jul 3. Cancer Immunol Immunother. 2018. PMID: 29971464 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,663 results

Search Page

Filters